publication venue for
- A randomized, placebo-controlled, double-blind trial to evaluate efficacy and safety of Shen-Yuan-Dan capsules, a traditional Chinese medicine, for treatment of peri-procedure myocardial injury following percutaneous coronary intervention. 69:102841-102841. 2022
- The quality of information available about Ephedra sinica on online vendor websites: The Canadian consumer experience.. 57:102674. 2021
- Multiple sclerosis clinical practice guidelines provide few complementary and alternative medicine recommendations: A systematic review.. 56:102595. 2021
- Complementary medicine mention and recommendations are limited across hypertension guidelines: A systematic review.. 50:102374. 2020
- Cannabinoids for spasticity due to multiple sclerosis or paraplegia: A systematic review and meta-analysis of randomized clinical trials. 34:170-185. 2017
- Methodology guideline for clinical studies investigating traditional Chinese medicine and integrative medicine. 23:751-756. 2015
- Shenqi pill, a traditional Chinese herbal formula, for the treatment of hypertension: A systematic review. 23:484-493. 2015
- Why West Africa rejected donation of Chinese medicine for treating Ebola recommended by Chinese government?. 23:505-507. 2015